Giulia Rossi

Giulia Rossi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FPFrancescaroberta Panuccio
Francescaroberta Panuccio
GRGiulia Rossi
Giulia Rossi
ANAnita Di Nuzzo
Anita Di Nuzzo
IRIlaria Ruotolo
Ilaria Ruotolo
GCGiada Cianfriglia
Giada Cianfriglia
Giovanni GaleotoGiovanni Galeoto
Giovanni Galeoto
Background/Objectives: Aphasia is a neurological condition affecting the ability to understand and/or express language fluently and accurately, and can occur following stroke, traumatic injuries, or other brain pathologies. The aim of the following study was to provide clinicians and researchers information regarding the existing assessment tools to assess aphasia. Methods: For this Systematic Review, PubMed, CINAHL, Web of Science, and Scopus were searched for articles published up to August 2024. Authors independently identified eligible studies based on predefined inclusion criteria and extracted data. The study quality and risk of bias were assessed using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist. Results: Of the 1278 publications identified and screened, 238 studies fell within the inclusion criteria and were critically reviewed, and 164 assessment tools were found and divided into 8 main domains; the most used tools were the Language Screening Test (LAST), the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39), the Oxford Cognitive Screen (OCS), and the Token test. Conclusions: This review has emphasized the need for agreement among researchers as to which tool must be studied or adapted to other national contexts to develop universal norms and standards.

17 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FPFrancescaroberta Panuccio
Francescaroberta Panuccio
GRGiulia Rossi
Giulia Rossi
ANAnita Di Nuzzo
Anita Di Nuzzo
IRIlaria Ruotolo
Ilaria Ruotolo
GCGiada Cianfriglia
Giada Cianfriglia
Giovanni GaleotoGiovanni Galeoto
Giovanni Galeoto
We would like to thank the authors of the commentary for the attention given to our work and for the observations provided, which we believe may contribute to improving the manuscript

5 September 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ASArianna Sterbini
Arianna Sterbini
PMPatrizia Marroni
Patrizia Marroni
ASAnnamaria Servadio
Annamaria Servadio
GRGiulia Rossi
Giulia Rossi
Anna BerardiAnna Berardi
Anna Berardi
Giovanni GaleotoGiovanni Galeoto
Giovanni Galeoto
The aim of this cross-sectional study was to translate, culturally adapt, and evaluate the psychometric properties of the Italian version of the Mann Assessment of Swallowing Ability (MASA) in post-stroke individuals. The original MASA scale was translated and culturally adapted from English to Italian following the international guidelines. The internal consistency and test–retest reliability of the MASA-IT were assessed, and its concurrent validity was examined through Pearson correlation coefficients with the Italian versions of two established gold standard scales for dysphagia assessment: the Dysphagia Outcome Severity Scale (DOSS) and the De Pippo Test—Three Oz Water Swallow. The MASA-IT was administered to 78 participants. The items demonstrated excellent internal consistency, with Cronbach’s alpha ranging between 0.86 and 0.89. The interclass correlation coefficient was 0.98 for inter-rater reliability and 0.99 for intra-rater reliability, indicating high reproducibility. Regarding concurrent validity, the MASA-IT showed a strong direct correlation with the DOSS scale (r = 0.949, p = 0.01) and an inverse correlation with the De Pippo Test (r = −0.783, p = 0.01), confirming its good concurrent validity. The Italian version of the Mann Assessment of Swallowing Ability (MASA-IT) is a reliable and valid tool for assessing swallowing ability in post-stroke patients. Its strong psychometric properties make it well suited for clinical use in Italy.